AIM ImmunoTech Amends Bylaws to Adopt 'Majority of Votes Cast' Voting Standard

AIM ImmunoTech Inc. announced that its Board of Directors approved an amendment to the company's bylaws, effective June 9, 2026, which changes the voting standard required to approve most stockholder proposals.

Key Details

• New Voting Standard: Proposals (other than the election of directors) will now be approved by a "majority of the votes cast." This counts only the votes cast "for" or "against" a proposal.
• Key Change: The new standard excludes abstentions and broker non-votes from the final tally. Previously, the standard required a majority of shares present and entitled to vote, effectively counting abstentions as votes against a proposal.
• Effective Date: The amendment was approved by the Board and became effective immediately on June 9, 2026.